An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)
Clinical trial NCT02831764 · COMPLETED
Trial details
- NCT number
- NCT02831764
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2018-04-04
- Enrollment
- 722
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.